329.83 USD
+0.09 (+0.03%)
329.83 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 69% to KRTX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 329.12. This target is -0.22% below the current price.
- KRTX was analyzed by 23 analysts. The buy percentage consensus is at 69. So analysts seem to be have mildly positive about KRTX.
- In the previous month the buy percentage consensus was at a similar level.
- KRTX was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-14 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-03-11 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-02-20 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2024-01-26 | Mizuho | Downgrade | Buy -> Neutral |
| 2024-01-17 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2023-12-28 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2023-12-26 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-12-22 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-12-22 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2023-12-22 | Wedbush | Downgrade | Outperform -> Neutral |
| 2023-12-22 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-12-12 | Deutsche Bank | Initiate | Buy |
| 2023-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-17 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-11-17 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-03 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-11-03 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-09-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-08 | B of A Securities | Maintains | Buy -> Buy |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2023-08-22 | Wells Fargo | Initiate | Overweight |
| 2023-08-04 | Mizuho | Maintains | Buy -> Buy |
| 2023-08-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-08-04 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-20 | Morgan Stanley | Initiate | Overweight |
| 2023-07-13 | William Blair | Maintains | Outperform -> Outperform |
| 2023-06-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-06-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
KARUNA THERAPEUTICS INC / KRTX FAQ
What is the average price target for KARUNA THERAPEUTICS INC (KRTX) stock?
23 analysts have analysed KRTX and the average price target is 329.12 USD. This implies a price decrease of -0.22% is expected in the next year compared to the current price of 329.83.
How do analysts rate KARUNA THERAPEUTICS INC (KRTX)?
The consensus rating for KARUNA THERAPEUTICS INC (KRTX) is 68.6957 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for KRTX stock?
The number of analysts covering KARUNA THERAPEUTICS INC (KRTX) is 23.